KELLY DAVIS: Open Payments
NPI 1225553803 · MENDOTA, IL. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$509 in 22 payments from 10 companies in 2025. Trend: 2023 $66 · 2024 $897 · 2025 $509
Food & beverage: $509
| Company | Payments | Amount |
|---|---|---|
| Regeneron Healthcare Solutions, Inc. | 4 | $122 |
| ITI, Inc. (d/b/a Intra-Cellular Therapies, Inc.) | 5 | $115 |
| UCB, Inc. | 2 | $60 |
| Otsuka America Pharmaceutical, Inc. | 2 | $54 |
| ABBVIE INC. | 2 | $42 |
| SUN PHARMACEUTICAL INDUSTRIES INC. | 2 | $33 |
| Astellas Pharma US Inc | 1 | $28 |
| Amgen Inc. | 1 | $23 |
| Organon LLC | 2 | $18 |
| Viatris Specialty LLC | 1 | $14 |
Products named: CAPLYTA, DUPIXENT, Bimzelx, REXULTI, VRAYLAR, LIBTAYO, ILUMYA, Veozah.
Industry payments across IL — which companies pay providers there.
